BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 14735471)

  • 21. PKCη/Rdx-driven phosphorylation of PDK1: a novel mechanism promoting cancer cell survival and permissiveness for parvovirus-induced lysis.
    Bär S; Rommelaere J; Nüesch JP
    PLoS Pathog; 2015 Mar; 11(3):e1004703. PubMed ID: 25742010
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evaluation of genetically engineered herpes simplex viruses as oncolytic agents for human malignant brain tumors.
    Andreansky S; Soroceanu L; Flotte ER; Chou J; Markert JM; Gillespie GY; Roizman B; Whitley RJ
    Cancer Res; 1997 Apr; 57(8):1502-9. PubMed ID: 9108452
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of intravenously administered recombinant vesicular stomatitis virus (VSV(deltaM51)) on multifocal and invasive gliomas.
    Lun X; Senger DL; Alain T; Oprea A; Parato K; Stojdl D; Lichty B; Power A; Johnston RN; Hamilton M; Parney I; Bell JC; Forsyth PA
    J Natl Cancer Inst; 2006 Nov; 98(21):1546-57. PubMed ID: 17077357
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Combination of measles virus virotherapy and radiation therapy has synergistic activity in the treatment of glioblastoma multiforme.
    Liu C; Sarkaria JN; Petell CA; Paraskevakou G; Zollman PJ; Schroeder M; Carlson B; Decker PA; Wu W; James CD; Russell SJ; Galanis E
    Clin Cancer Res; 2007 Dec; 13(23):7155-65. PubMed ID: 18056196
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Retargeting of rat parvovirus H-1PV to cancer cells through genetic engineering of the viral capsid.
    Allaume X; El-Andaloussi N; Leuchs B; Bonifati S; Kulkarni A; Marttila T; Kaufmann JK; Nettelbeck DM; Kleinschmidt J; Rommelaere J; Marchini A
    J Virol; 2012 Apr; 86(7):3452-65. PubMed ID: 22258256
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Adenoviral vectors expressing fusogenic membrane glycoproteins activated via matrix metalloproteinase cleavable linkers have significant antitumor potential in the gene therapy of gliomas.
    Allen C; McDonald C; Giannini C; Peng KW; Rosales G; Russell SJ; Galanis E
    J Gene Med; 2004 Nov; 6(11):1216-27. PubMed ID: 15459967
    [TBL] [Abstract][Full Text] [Related]  

  • 27. SMAD4: a predictive marker of PDAC cell permissiveness for oncolytic infection with parvovirus H-1PV.
    Dempe S; Stroh-Dege AY; Schwarz E; Rommelaere J; Dinsart C
    Int J Cancer; 2010 Jun; 126(12):2914-27. PubMed ID: 19856310
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cytotoxicity, apoptosis, and viral replication in tumor cells treated with oncolytic ribonucleotide reductase-defective herpes simplex type 1 virus (hrR3) combined with ionizing radiation.
    Spear MA; Sun F; Eling DJ; Gilpin E; Kipps TJ; Chiocca EA; Bouvet M
    Cancer Gene Ther; 2000 Jul; 7(7):1051-9. PubMed ID: 10917208
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Oncolytic murine autonomous parvovirus, a candidate vector for glioma gene therapy, is innocuous to normal and immunocompetent mouse glial cells.
    Abschuetz A; Kehl T; Geibig R; Leuchs B; Rommelaere J; Régnier-Vigouroux A
    Cell Tissue Res; 2006 Sep; 325(3):423-36. PubMed ID: 16699801
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Replication-deficient vaccinia virus gene therpay vector: evaluation of exogenous gene expression mediated by PUV-inactivated virus in glioma cells.
    Timiryasova TM; Chen B; Fodor I
    J Gene Med; 2001; 3(5):468-77. PubMed ID: 11601760
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Treatment of cholangiocarcinoma with oncolytic herpes simplex virus combined with external beam radiation therapy.
    Jarnagin WR; Zager JS; Hezel M; Stanziale SF; Adusumilli PS; Gonen M; Ebright MI; Culliford A; Gusani NJ; Fong Y
    Cancer Gene Ther; 2006 Mar; 13(3):326-34. PubMed ID: 16138120
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pediatric and Adult High-Grade Glioma Stem Cell Culture Models Are Permissive to Lytic Infection with Parvovirus H-1.
    Josupeit R; Bender S; Kern S; Leuchs B; Hielscher T; Herold-Mende C; Schlehofer JR; Dinsart C; Witt O; Rommelaere J; Lacroix J
    Viruses; 2016 May; 8(5):. PubMed ID: 27213425
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Suberoylanilide hydroxamic acid (SAHA) has potent anti-glioma properties in vitro, ex vivo and in vivo.
    Eyüpoglu IY; Hahnen E; Buslei R; Siebzehnrübl FA; Savaskan NE; Lüders M; Tränkle C; Wick W; Weller M; Fahlbusch R; Blümcke I
    J Neurochem; 2005 May; 93(4):992-9. PubMed ID: 15857402
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Survivin-driven and fiber-modified oncolytic adenovirus exhibits potent antitumor activity in established intracranial glioma.
    Ulasov IV; Zhu ZB; Tyler MA; Han Y; Rivera AA; Khramtsov A; Curiel DT; Lesniak MS
    Hum Gene Ther; 2007 Jul; 18(7):589-602. PubMed ID: 17630837
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Changes in gene expression profiles induced by parvovirus H-1 in human gastric cancer cells.
    Liu J; Ran ZH; Xiao SD; Rommelaere J
    Chin J Dig Dis; 2005; 6(2):72-81. PubMed ID: 15904425
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Functional analysis and quantitative determination of the expression profile of human parvovirus B19.
    Bonvicini F; Filippone C; Manaresi E; Zerbini M; Musiani M; Gallinella G
    Virology; 2008 Nov; 381(2):168-77. PubMed ID: 18838151
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Generation of an adenovirus-parvovirus chimera with enhanced oncolytic potential.
    El-Andaloussi N; Bonifati S; Kaufmann JK; Mailly L; Daeffler L; Deryckère F; Nettelbeck DM; Rommelaere J; Marchini A
    J Virol; 2012 Oct; 86(19):10418-31. PubMed ID: 22787235
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Highly efficient transduction and expression of cytokine genes in human tumor cells by means of autonomous parvovirus vectors; generation of antitumor responses in recipient mice.
    Haag A; Menten P; Van Damme J; Dinsart C; Rommelaere J; Cornelis JJ
    Hum Gene Ther; 2000 Mar; 11(4):597-609. PubMed ID: 10724038
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Gene therapy for malignant glioma using Sindbis vectors expressing a fusogenic membrane glycoprotein.
    Zhang J; Frolov I; Russell SJ
    J Gene Med; 2004 Oct; 6(10):1082-91. PubMed ID: 15368589
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Development of an improved method of detection of infectious parvovirus B19.
    Wong S; Brown KE
    J Clin Virol; 2006 Apr; 35(4):407-13. PubMed ID: 16455300
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.